Monitoring minimal residual disease.
Gribben
J G
JG
Department of Medicine, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA 02115.
Nadler
L M
LM
D001856:Bone Marrow Examination; D005821:Genetic Techniques; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D015166:Monitoring, Immunologic; D012074:Remission Induction; D015996:Survival Rate